Background & Aims

Nocebo hyperalgesia manifests itself by increasing pain following sham (placebo) intervention [1,2]. Although this phenomenon is frequently observed in clinical practice, relatively little research has been aimed at the search for procedures that could attenuate the acquired nocebo effect. The current pilot study investigates the efficacy of counterconditioning, verbal modeling, and operant conditioning in reducing nocebo hyperalgesia induced by classical conditioning.
The additional study goal is to investigate the role of expectancy and stress in the formation and attenuation of nocebo hyperalgesia.?

Methods

Three experimental groups and one control were formed to investigate nocebo effects. In the nocebo induction phase, low-intensity electrical stimuli were administered without a placebo, while high-intensity stimuli were given with a placebo. Moderate stimuli were also applied with and without a placebo to assess nocebo hyperalgesia. In the nocebo attenuation phase, participants underwent various interventions: 1) low-intensity stimuli with a placebo and high-intensity stimuli without a placebo (counterconditioning), 2) moderate-intensity stimuli with- and without a placebo, coupled with rewards for low pain ratings following placebo (operant conditioning), 3) moderate-intensity stimuli with- and without a placebo, accompanied by exposure to others’ pain ratings indicating low pain when the placebo was applied (verbal modeling). Next, moderate stimuli were administered with and without a placebo to evaluate the impact of the interventions on attenuating nocebo hyperalgesia.

Results

Data collection is ongoing, the results and conclusions will be presented on the poster.

Conclusions

Data collection is ongoing, the results and conclusions will be presented on the poster.

References

[1] Thomaidou, M. A., Veldhuijzen, D. S., Peerdeman, K. J., Wiebing, N. Z. S., Blythe, J. S., & Evers, A. W. M. (2020). Learning mechanisms in nocebo hyperalgesia: the role of conditioning and extinction processes. Pain, 161(7), 1597–1608.

[2] Karacaoglu, M., Peerdeman, K. J., Numans, M. E., Stolk, M. R., Meijer, S., Klinger, R., Veldhuijzen, D. S., van Middendorp, H., & Evers, A. W. M. (2023). Nocebo Hyperalgesia in Patients With Fibromyalgia and Healthy Controls: An Experimental Investigation of Conditioning and Extinction Processes at Baseline and 1-Month Follow-up. The journal of pain, 24(9), 1696–1711.

Presenting Author

Izabela Laska

Poster Authors

Izabela Laska

BSc

Uniwersytet Jagiello?ski

Lead Author

El?bieta A. Bajcar

PhD

Jagiellonian University

Lead Author

Daryna Rubanets

Doctoral School in the Social Sciences, Jagiellonian University, Kraków, Poland

Lead Author

Joanna K?osowska (Phd)

Jagiellonian University, Institute of Psychology, Pain Research Group, Kraków, Poland

Lead Author

Przemys?aw B?bel

Prof.

Jagiellonian University, Institute of Psychology, Pain Research Group

Lead Author

Topics

  • Placebo